广州银诺医药集团创始人及高管承诺自2026年8月15日起六个月股份锁定期

美股速递
Sep 07

广州银诺医药集团股份有限公司(Innogen Pharmaceutical Group Co.)宣布,公司创始人及高级管理层已承诺自2026年8月15日起实施为期六个月的股份锁定期。此举彰显了核心团队对公司长期发展前景的坚定信心,同时也有助于稳定市场预期,传递出积极的治理信号。锁定期安排从8月中旬正式启动,届时相关方将在此期间不转让或处置所持股份,以进一步维护股东利益并支持公司战略稳步推进。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10